Publication | Closed Access

Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography

ThrombosisHemodialysisCardiovascular DiseaseMedicinePharmacologyPharmacotherapyRenal Toxicity EvaluationComparison Between VisipaquePublic HealthCardiovascular ToxicityChronic Kidney DiseaseAnticoagulantAtherosclerosisNephrologyCoronary Artery DiseaseAnesthesiologyCardiovascular Imaging